CLINICAL AND ECONOMIC OUTCOMES OF LATANOPROST BIMATOPROST OR TRAVOPROST THERAPY IN GLAUCOMA PATIENTS: A THREE-MONTH RETRO-SPECTIVE STUDY

作     者：G.F.Schwartz C.P.Schaefer Y.C.Yeh J.Nordin E.Mozaffari 

作者机构：Glaucoma Consultants Greater Baltimore Medical Center Wilmer Eye Institute Johns Hopkins and The University of Maryland MDCovance Health Eco-nomics and Outcomes Services Inc. MDCovance Health Eco-nomics and Outcomes Services Inc. MDCovance Health Eco-nomics and Outcomes Services Inc. MDPharmacia Corpo-ration NJ USA 

出 版 物：《国际眼科杂志》 (International Eye Science)

年 卷 期：2003年第3卷第1期

页      面：87-88页

学科分类：1007[医学-药学(可授医学、理学学位)] 1002[医学-临床医学] 100212[医学-眼科学] 10[医学] 

主　　题：拉坦前列素 Bimatoprost 曲福前列素 青光眼 药物治疗 治疗药用 临床分析 

摘      要：Purpose: To evaluate rates of hyperemia in patients treated with latanoprost, bimatoprost, or travoprost and to compare groups in IOP response and costs. Methods: This 3-month, retrospective, multicenter, non-randomized, medical chart review included patients from 10 U.S. sites, who either initiated or changed to latanoprost, bimatoprost, or travoprost for the treatment of primary open-angle glaucoma or ocular hypertension after January 1, 2001. Patients had follow-up data for at least 3 months fol-